Sechenov School
Home › Pathology › Parenchymal Lipid Dystrophy

Parenchymal Lipid Dystrophies

Dystrophiae parenchymatosae lipidicae

For medical students2 min readUpdated 2026-10-10

Parenchymal lipid dystrophies (lipidosis) are disorders of intracellular lipid metabolism characterized by the abnormal accumulation of neutral fats, phospholipids, or cholesterol esters. These pathological changes lead to the appearance of lipids in cells where they are normally absent or to an increase in their amount within physiological storage sites.

Hepatic steatosisFat is identified in more than 50% of hepatocytes
"Tiger-stripe heart"Yellow-white myocardial striation due to hypoxia or toxins
Sudan stainsStain lipids orange, red, or black
ThesaurismosesHereditary systemic lipid storage diseases (e.g., Gaucher disease)

Core Process and Mechanisms of Accumulation

Lipidoses refer to morphological changes in which triglycerides and cholesterol esters accumulate in the cytoplasm of parenchymal cells. Three key morphogenetic mechanisms underlie this process: cellular infiltration with excess lipids, decomposition (breakdown of membrane lipoprotein complexes, or phanerosis), and aberrant synthesis. The liver, myocardium, and kidneys are most frequently affected.

Fatty Liver (Steatosis)

The liver is most frequently involved due to its central role in triglyceride metabolism. Normally, free fatty acids are converted into lipoproteins within hepatocytes with the assistance of apoproteins for export into the bloodstream. When enzymes are blocked, protein malnutrition occurs, or there is an excessive influx of fatty acids, this mechanism is disrupted.

Myocardial and Renal Involvement

In the myocardium, fatty change develops against a backdrop of energy deficit and hypoxia, as well as in diphtheria intoxication due to blockade of the carnitine shuttle mechanism. Grossly, yellow bands are visible beneath the endocardium of the left ventricle ("tiger-stripe heart").

In the kidneys, lipids accumulate in the epithelium of the proximal and distal tubules, primarily in nephrotic syndrome due to massive proteinuria and concomitant hyperlipidemia, which leads to lipiduria and increased reabsorption.

Histochemical Diagnostic Methods

Frozen tissue sections are used to verify lipid dystrophies so that lipids do not dissolve during tissue processing:

  1. Sudan III — stains neutral fats orange.
  2. Sudan IV and Scarlet Red — impart a red hue.
  3. Osmium tetroxide and Sudan Black B — stain lipids black.
  4. Nile Blue Sulfate — differentiates free fatty acids (dark blue) from neutral fats (red).

Mnemonic

To remember Sudan fat staining, use the phrase: "Sudan Three is orange to see, Sudan Four is red at the core."

Frequently asked questions

What microscopic types of hepatocyte fatty change are distinguished based on the size of the lipid droplets?

Depending on the size of the lipid inclusions within hepatocytes, three types of fatty change are distinguished:

  • Microvesicular steatosis — small membrane-bound vacuoles are localized in the cytoplasm, and the cell nucleus remains centrally located.
  • Mesovesicular steatosis — an intermediate variant of lipid accumulation.
  • Macrovesicular steatosis — the extreme expression of the process, in which a giant lipid vacuole displaces the hepatocyte nucleus to the outer cell membrane (periphery), while a thin rim of lipid-free cytoplasm remains structurally and functionally intact.
What are the possible outcomes of parenchymal fatty liver disease?

The possible outcomes of parenchymal fatty liver disease depend on the form of the condition and the duration of exposure to the etiologic factor.

  • Reversible outcome: With complete abstinence in alcoholic steatosis, fat disappears from the liver within 2 to 4 weeks.
  • Progression to cirrhosis: Prolonged alcohol consumption leads to hepatic cirrhosis; recurrent bouts of acute alcoholic hepatitis play an important role.
  • Severe hepatic dysfunction: Characteristic of acute fatty liver, which represents a manifestation of massive progressive hepatic necrosis.
  • In chronic fatty change, liver function may be depressed, but even in severe chronic steatosis, clinical manifestations of dysfunction are rare.
What is phanerosis in parenchymal dystrophies?

Phanerosis is a mechanism of decomposition involving the breakdown of masked (bound) lipoprotein complexes within intracellular structures and membranes, resulting in the appearance of free neutral fats in the cytoplasm.

What are the main causes of myocardial fatty change?

The primary causes are chronic hypoxia (associated with anemias and heart failure) and severe intoxications, including diphtheria exotoxin, which blocks the mitochondrial utilization of fatty acids.

Why does protein deficiency lead to fatty liver?

Protein malnutrition impairs the synthesis of apoproteins in hepatocytes. Without transport proteins, triglycerides cannot be packaged into lipoproteins to leave the cell, leading to their intracellular accumulation.

Go deeper

More topics in Pathology

Osteomyelitis and Related Bone PathologiesHemolytic Disease of the NewbornScarlet Fever and Childhood InfectionsTeratoma: Pathogenesis, Morphology and ClassificationDental CariesCentral Nervous System InfectionsPathogenesis of NecrosisRegenerationCellular Inflammatory MediatorsCellular ImmunityRheumatic FeverMorphology of Chronic Venous CongestionPathology →